#1 Clinical Trials Search in Europe

Find a Clinical Trial

Search Trials by Disease

Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
Rare Diseases Treatments

Search Trials by Disease

Primitive neuroectodermal tumour Polycythaemia vera Follicular lymphoma Idiopathic intracranial hypertension Hypocalcaemia Neuronal ceroid lipofuscinosis Leiomyosarcoma recurrent Thrombocytosis Dupuytren's contracture Systemic lupus erythematosus Prolymphocytic leukaemia Krabbe's disease Duchenne muscular dystrophy gene carrier Narcolepsy Alternating hemiplegia of childhood More trials…
Learn about Rare Diseases

Cholangitis sclerosing – Diagnostics Ewing’s sarcoma Congenital nephrogenic diabetes insipidus – Trials in Disease Alveolar rhabdomyosarcoma – Trials in Disease Wolfram syndrome – Diagnostics Systemic sclerosis pulmonary – Trials in Disease Phenylketonuria – Life with Disease Small intestine leiomyosarcoma – Treatment Turner’s syndrome – Basic Information Antisynthetase syndrome – Life with Disease More diseases
Vaccine Clinical Trials
Pediatric Clinical Trials
Resources for Patients

Browse Innovative Treatments

Bleomycin Sulfate Ph. Eur. PEGVISOMANT Dextromethorphan Hydrobromide Alpha-Tocopherol Tigulixostat Ds-3939A Alizapride Exidavnemab Tivozanib Cisatracurium Besilate Human Vaccinia Immunoglobulin HUMAN THROMBIN Epinephrine Img-007 Asp1570 Levodopa Mps-216 Alrefimotide Human Von Willebrand Factor Aztreonam More therapies…

Learn about Your Condition

Hepatic fibrosis Anogenital dysplasia Transient ischaemic attack Basal cell carcinoma Lymphocytic leukaemia Vulvar dysplasia Congenital pseudarthrosis Hyponatraemia Colorectal cancer metastatic Endometrial cancer stage III Tuberculosis Progressive multiple sclerosis Iron deficiency Vascular calcification Post-traumatic stress disorder More diseases
Healthy Volunteers
Patient Guide
Our Partners
About Us
Contact us
Region

🇪🇺 Europe
🇦🇹 Austria
🇭🇷 Croatia
🇨🇿 Czech Republic
🇩🇰 Denmark
🇪🇪 Estonia
🇫🇮 Finland
🇫🇷 France
🇩🇪 Germany
🇮🇸 Iceland
🇮🇹 Italy
🇱🇻 Latvia
🇱🇹 Lithuania
🇳🇱 Netherlands
🇳🇴 Norway
🇵🇱 Poland
🇵🇹 Portugal
🇷🇴 Romania
🇸🇰 Slovakia
🇸🇮 Slovenia
🇪🇸 Spain
🇸🇪 Sweden

Haemophilia A without inhibitors

Study on the Effects and Safety of Emicizumab for Infants with Hemophilia A (Ages Birth to 12 Months)

Not recruiting

3 1 1 1
Investigated Diseases:
- Haemophilia A without inhibitors
Investigated Drugs:
- Emicizumab
Study on Health, Activity, and Joint Outcomes in Patients Aged 13-69 with Severe or Moderate Hemophilia A Using Emicizumab

Not recruiting

3 1 1 1
Investigated Drugs:
- Emicizumab
Study on the Safety and Effectiveness of SerpinPC for Patients with Severe Hemophilia A or B

Not recruiting

2 1 1
Investigated Diseases:
+1

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

Haemophilia A without inhibitors

Study on the Effects and Safety of Emicizumab for Infants with Hemophilia A (Ages Birth to 12 Months)

Study on Health, Activity, and Joint Outcomes in Patients Aged 13-69 with Severe or Moderate Hemophilia A Using Emicizumab

Study on the Safety and Effectiveness of SerpinPC for Patients with Severe Hemophilia A or B

Investigational Drugs in This Location

Medical Conditions Being Studied in This Location

We use cookies